Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Artificial Organs|March 7, 2002
Polyetherimide: a new membrane-forming polymer for biomedical applicationsB Seifert, G Mihanetzis, T Groth, et al.
Journal of Materials Science. Materials in Medicine|September 7, 2004
Functionality of MDCK kidney tubular cells on flat polymer membranes for biohybrid kidneyF Fey-Lamprecht, U Gross, T H Groth, et al.
Plos One|May 15, 2009
Genome-wide massively parallel sequencing of formaldehyde fixed-paraffin embedded (FFPE) tumor tissues for copy-number- and mutation-analysisMichal R Schweiger, Martin Kerick, Bernd Timmermann, et al.
Computers in Biology and Medicine|July 14, 2020
Semi-supervised labelling of the femur in a whole-body post-mortem CT database using deep learningC A Peña-Solórzano, D W Albrecht, R B Bassed, et al.
Actas Urologicas Espanolas|December 23, 2011
[EAU guidelines on testicular cancer: 2011 update. European Association of Urology]P Albers, W Albrecht, F Algaba, et al.
Acta Neurochirurgica|March 13, 2003
Magnesium therapy after aneurysmal subarachnoid haemorrhage a dose-finding study for long term treatmentW M van den Bergh, K W Albrecht, J W Berkelbach van der Sprenkel, et al.
Genetics|August 28, 2013
Coordination and processing of DNA ends during double-strand break repair: the role of the bacteriophage T4 Mre11/Rad50 (MR) complexJoshua R Almond, Bradley A Stohr, Anil K Panigrahi, et al.
Experimental Aging Research|April 1, 1994
Assessment of intellectual functioning of patients with Parkinson's disease using the Satz-Mogel (1962) short form of the Wechsler Adult Intelligence ScaleN N Albrecht, S D Netherton, J W Elias, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 16, 2000
Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the NetherlandsY B Roos, R J de Haan, L F Beenen, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 13, 2007
In vitro metabolite identification of ML3403, a 4-pyridinylimidazole-type p38 MAP kinase inhibitor by LC-Qq-TOF-MS and LC-SPE-cryo-NMR/MSB Kammerer, H Scheible, G Zurek, et al.
Pageof 13